Page last updated: 2024-08-25

3-deazaneplanocin and Libman-Sacks Disease

3-deazaneplanocin has been researched along with Libman-Sacks Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Farkash, EA; He, Y; Rohraff, DM; Sawalha, AH; Schonfeld, M; Tsou, PS	1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and Libman-Sacks Disease

Article	Year
Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice. Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:10 Topics: Adenosine; Adult; Animals; Antibodies, Antinuclear; Antibody Formation; B-Lymphocytes; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Lymph Nodes; Lymphocyte Count; Male; Mice; Mice, Inbred MRL lpr; Middle Aged; Monocytes; Neutrophils; Proteinuria; RNA, Messenger; Spleen; Survival Rate; T-Lymphocytes	2019

Article

Year

Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.

Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:10

Topics: Adenosine; Adult; Animals; Antibodies, Antinuclear; Antibody Formation; B-Lymphocytes; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Lymph Nodes; Lymphocyte Count; Male; Mice; Mice, Inbred MRL lpr; Middle Aged; Monocytes; Neutrophils; Proteinuria; RNA, Messenger; Spleen; Survival Rate; T-Lymphocytes

2019